Evidence map›Paper›PMID 27697800›Full record

ArticleClinical medicine (London, England)2016

Iatrogenic Cushing's syndrome due to drug interaction between glucocorticoids and the ritonavir or cobicistat containing HIV therapies.

Emilie R Elliot, Aikaterini Theodoraki, Lakshmi R Jain, Neal J Marshall, Marta Boffito, Stephanie E Baldeweg, Laura J Waters

Open access · diamondAbstract read
In one paragraph

Article in Clinical medicine (London, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Review
  3. Observational
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Multiple vertebral compression fractures in a human immunodeficiency virus-positive patient with glucocorticoid-induced Cushing syndrome treated with percutaneous vertebroplasty: a case report.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2021
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. The challenge of HIV treatment in an era of polypharmacy.Journal of the International AIDS Society · 2020
    Review
  15. Article
  16. Human Immunodeficiency Virus Infection and the Endocrine System.Endocrinology and metabolism (Seoul, Korea) · 2019
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Emilie R ElliotChelsea and Westminster Hospital, London, UK emilieelliot@doctors.net.uk.
Aikaterini TheodorakiUniversity College London Hospitals Foundation Trust, London, UK.
Lakshmi R JainMortimer Market Centre, London, UK.
Neal J MarshallIan Charleson Centre for HIV Medicine, Royal Free London NHS Foundation Trust, London, UK.
Marta BoffitoChelsea and Westminster Hospital, London, UK.
Stephanie E BaldewegUniversity College London Hospitals Foundation Trust, London, UK.
Laura J WatersMortimer Market Centre, London, UK.
Chelsea and Westminster Hospital · GBMortimer Market Centre · GBUniversity College London · GBRoyal Free London NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ritonavir and cobicistat, used as pharmacokinetic enhancers in combination with some antiretrovirals (ARVs) for the treatment of HIV, are potent inhibitors of the CYP3A4 isoenzyme. Most glucocorticoids are metabolised via the CYP3A4 pathway and iatrogenic Cushing's syndrome (ICS), with possible secondary adrenal insufficiency (SAI), is a recognised complication following co-administration with ritonavir or cobicistat. A structured approach for identifying and managing potentially affected individuals has not been established.We systematically identified patients with ICS/SAI and found substantial heterogeneity in clinical practice across three large London HIV centres. While this significant drug interaction and its complications are now well-recognised, it is apparent that there is no standardised approach to management or guidance for the general physician. Here we describe the management of ICS/SAI in our current practice, review the available evidence and suggest practice recommendations.

Indexed as

AdultAnti-HIV AgentsCobicistatCushing SyndromeDrug InteractionsFemaleGlucocorticoidsHIV InfectionsHumansIatrogenic DiseaseMaleMedical AuditMiddle AgedRetrospective StudiesRitonavirAnti-HIV AgentsCobicistatGlucocorticoidsRitonavirAdrenal insufficiencycobicistatCushing’s syndromeHIVritonavir

Identifiers

PMID27697800
PMCPMC6297313
OpenAlexW2528273673

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.